Windsor Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
PCA
MSV
CNB
BTCPP
VFA
GIA
CAM
EB
Windsor Capital Management's LLY Position: Q3 2026 in Review
Windsor Capital Management increased its Eli Lilly (LLY) stake by 1.2% in Q3 2026, buying an estimated $3.54K and bringing the position to 263 shares worth $304K. The position accounts for 0.08% of the portfolio, ranked #105.
Windsor Capital Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $312K in Q2 2026. 428 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Windsor Capital Management held 263 shares of Eli Lilly worth $304K as of Q3 2026.
- Windsor Capital Management bought 3 Eli Lilly shares in Q3 2026, an estimated $3.54K.
- Eli Lilly made up 0.08% of Windsor Capital Management's portfolio in Q3 2026, its #105 holding.
- Windsor Capital Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Windsor Capital Management's Eli Lilly position peaked at $312K in Q2 2026.
- 428 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Windsor Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.